%CD5+IgM+ (median;range) | %BAFF-R+ve | BAFF-R+ve (MFI) | BAFF levels (ng/ml) (median;range) | |
---|---|---|---|---|
HC | 18.5 (9.1–26.8) | 98.7 (97.9–99.5) | 62.5 (50.5–82.4) | 1.1 (0.9–1.2) |
Pre-RTX | 5.4 (1.9–21.4) | 97.3 (85.8–100) | 58 (34.2–139) | 1.4 (0.9–1.7) |
Post-RTX early relapse | 44.4 (39.6–55.8) **###$$ | 60.6 (12.9–71.2)**###$$ | 15.6 (11.8–17.5)**###$$ | 2.4 (2–6.4)**###$ |
Post-RTX late relapse | 12.7 (2.3–27.9)$$ | 93.1 (81.5–97.9)**$$ | 30.2 (19.9–36)**##$$ | 1.7 (1.3–2.4)**#$ |
*p<0.05; **p<0.01; ***p<0.001 compared with NC; #p<0.05; ##p<0.01; ###p<0.001 compared with pre-RTX; $p<0.05; $$p<0.01; $$$p<0.001 for comparisons between post-RTX groups.